Infection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at a late stage in the virus life cycle

Journal of Virology

Volumn 89, Issue 24, 2015, Pages 12319-12329

  Londrigan, Sarah L ^a,b   Short, Kirsty R ^a,b   Ma, Joel ^a,b   Gillespie, Leah ^a,b   Rockman, Steven P ^c   Brooks, Andrew G ^a,b   Reading, Patrick C ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

^c PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOPROTEIN; HEMAGGLUTININ; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; SIALIDASE; VIRUS PROTEIN; VIRUS RNA; HEMAGGLUTININ, HUMAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; NA PROTEIN, INFLUENZA A VIRUS; VIRAL PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE REPLICATION; GENETIC TRANSCRIPTION; INFLUENZA A VIRUS; INFLUENZA VIRUS; LIFE CYCLE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; VIRUS RELEASE; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DOG; GENETICS; HUMAN; MDCK CELL LINE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; SPECIES DIFFERENCE; VIROLOGY;

ANIMALS; CELL MEMBRANE; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MACROPHAGES; MADIN DARBY CANINE KIDNEY CELLS; MICE; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; RNA, VIRAL; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84949755414     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01455-15     Document Type: Article

References (44)

1. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
2. Short KR, Brooks AG, Reading PC, Londrigan SL. 2012. The fate of influenza A virus after infection of human macrophages and dendritic cells. J Gen Virol 93:2315-2325. http://dx.doi.org/10.1099/vir.0.045021-0.
3. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC. 2010. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 84:7569-7580. http://dx.doi.org/10.1128/JVI.00291-10.
4. Kim HM, Kang YM, Ku KB, Park EH, Yum J, Kim JC, Jin SY, Lee JS, Kim HS, Seo SH. 2013. The severe pathogenicity of alveolar macrophagedepleted ferrets infected with 2009 pandemic H1N1 influenza virus. Virology 444:394-403. http://dx.doi.org/10.1016/j.virol.2013.07.006.
5. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, van Rooijen N, Guan Y, Seo SH. 2008. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol 82:4265-4274. http://dx.doi.org/10.1128/JVI.02602-07.
6. Upham JP, Pickett D, Irimura T, Anders EM, Reading PC. 2010. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84:3730-3737.http://dx.doi.org/10.1128/JVI.02148-09.
7. Reading PC, Miller JL, Anders EM. 2000. Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74:5190-5197.http://dx.doi.org/10.1128/JVI.74.11.5190-5197.2000.
8. Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL, Reading PC. 2014. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J Virol 88:1659-1672. http://dx.doi.org/10.1128/JVI.02014-13.
9. Reading PC, Whitney PG, Pickett DL, Tate MD, Brooks AG. 2010. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol Cell Biol 88:641-650. http://dx.doi.org/10.1038/icb.2010.11.
10. Rodgers B, Mims CA. 1981. Interaction of influenza virus with mouse macrophages. Infect Immun 31:751-757.
11. Cline TD, Karlsson EA, Seufzer BJ, Schultz-Cherry S. 2013. The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J Virol 87:1411-1419. http://dx.doi.org/10.1128/JVI.02682-12.
12. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345-9350. http://dx.doi.org/10.1073/pnas.96.16.9345.
13. Anders EM, Hartley CA, Jackson DC. 1990. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A 87:4485-4489. http://dx.doi.org/10.1073/pnas.87.12.4485.
14. Londrigan SL, Tate MD, Brooks AG, Reading PC. 2012. Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus. J Leukoc Biol 92:97-106. http://dx.doi.org/10.1189/jlb.1011492.
15. Livak KJ, Wills QF, Tipping AJ, Datta K, Mittal R, Goldson AJ, Sexton DW, Holmes CC. 2013. Methods for qPCR gene expression profiling applied to 1440 lymphoblastoid single cells. Methods 59:71-79. http://dx.doi.org/10.1016/j.ymeth.2012.10.004.
16. Short KR, Reading PC, Brown LE, Pedersen J, Gilbertson B, Job ER, Edenborough KM, Habets MN, Zomer A, Hermans PW, Diavatopoulos DA, Wijburg OL. 2013. Influenza-induced inflammation drives pneumococcal otitis media. Infect Immun 81:645-652. http://dx.doi.org/10.1128/IAI.01278-12.
17. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275-2289. http://dx.doi.org/10.1007/s007050170002.
18. Tate MD, Brooks AG, Reading PC. 2011. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J Immunol 187:1884-1894. http://dx.doi.org/10.4049/jimmunol.1100295.
19. Wells MA, Albrecht P, Daniel S, Ennis FA. 1978. Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun 22:758-762.
20. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4:e1000115. http://dx.doi.org/10.1371/journal.ppat.1000115.
21. Chan RW, Leung CY, Nicholls JM, Peiris JS, Chan MC. 2012. Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses. PLoS One 7:e51057. http://dx.doi.org/10.1371/journal.pone.0051057.
22. Gong J, Xu W, Zhang J. 2007. Structure and functions of influenza virus neuraminidase. Curr Med Chem 14:113-122. http://dx.doi.org/10.2174/092986707779313444.
23. Amorim MJ, Bruce EA, Read EK, Foeglein A, Mahen R, Stuart AD, Digard P. 2011. A Rab11-and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. J Virol 85:4143-4156.http://dx.doi.org/10.1128/JVI.02606-10.
24. Tate MD, Brooks AG, Reading PC. 2011. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microbes Infect 13:202-207. http://dx.doi.org/10.1016/j.micinf.2010.10.004.
25. Lohmeyer J, Talens LT, Klenk HD. 1979. Biosynthesis of the influenza virus envelope in abortive infection. J Gen Virol 42:73-88.
26. Lau SC, Scholtissek C. 1995. Abortive infection of Vero cells by an influenza A virus (FPV). Virology 212:225-231. http://dx.doi.org/10.1006/viro.1995.1473.
27. Veit M, Serebryakova MV, Kordyukova LV. 2013. Palmitoylation of influenza virus proteins. Biochem Soc Trans 41:50-55. http://dx.doi.org/10.1042/BST20120210.
28. Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S, Reading PC. 2014. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 6:1294-1316. http://dx.doi.org/10.3390/v6031294.
29. Pal S, Santos A, Rosas JM, Ortiz-Guzman J, Rosas-Acosta G. 2011. Influenza A virus interacts extensively with the cellular SUMOylation system during infection. Virus Res 158:12-27. http://dx.doi.org/10.1016/j.virusres.2011.02.017.
30. Regan JF, Liang Y, Parslow TG. 2006. Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA. J Virol 80:252-261. http://dx.doi.org/10.1128/JVI.80.1.252-261.2006.
31. McAuley JL, Zhang K, McCullers JA. 2010. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84:558-564. http://dx.doi.org/10.1128/JVI.01785-09.
32. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. 2008. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10: 1140-1152. http://dx.doi.org/10.1111/j.1462-5822.2008.01116.x.
33. Rossman JS, Lamb RA. 2011. Influenza virus assembly and budding. Virology 411:229-236. http://dx.doi.org/10.1016/j.virol.2010.12.003.
34. Gujuluva CN, Kundu A, Murti KG, Nayak DP. 1994. Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Virology 204:491-505. http://dx.doi.org/10.1006/viro.1994.1563.
35. Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D. 2013. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol 87:13053-13058. http://dx.doi.org/10.1128/JVI.02220-13.
36. Pavlovic J, Zurcher T, Haller O, Staeheli P. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370-3375.
37. Siegrist F, Ebeling M, Certa U. 2011. The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res 31:183-197.http://dx.doi.org/10.1089/jir.2010.0112.
38. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL. 2011. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337. http://dx.doi.org/10.1371/journal.ppat.1002337.
39. Winkler M, Bertram S, Gnirss K, Nehlmeier I, Gawanbacht A, Kirchhoff F, Ehrhardt C, Ludwig S, Kiene M, Moldenhauer AS, Goedecke U, Karsten CB, Kuhl A, Pohlmann S. 2012. Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFNdependent tetherin expression in infected cells. PLoS One 7:e43337. http://dx.doi.org/10.1371/journal.pone.0043337.
40. Watanabe R, Leser GP, Lamb RA. 2011. Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology 417:50-56. http://dx.doi.org/10.1016/j.virol.2011.05.006.
41. Wang J, Nikrad MP, Travanty EA, Zhou B, Phang T, Gao B, Alford T, Ito Y, Nahreini P, Hartshorn K, Wentworth D, Dinarello CA, Mason RJ. 2012. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One 7:e29879. http://dx.doi.org/10.1371/journal.pone.0029879.
42. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30:556-565. http://dx.doi.org/10.1016/j.immuni.2009.02.005.
43. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS. 2011. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 85:11557-11566. http://dx.doi.org/10.1128/JVI.05519-11.
44. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Jr, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat Med 19:458-464. http://dx.doi.org/10.1038/nm.3108.